Theravance Biopharma, Inc. (TBPH)

20.37 -0.05 (-0.24%) USD  |  NASDAQ  |  Jan 21, 16:00
20.35 -0.02 (-0.10%) After-Hours: 05:47
More

Theravance Biopharma Net Total Long Term Debt (Quarterly)

Net Total Long Term Debt (Quarterly) Chart

View Net Total Long Term Debt (Quarterly) for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Total Long Term Debt (Quarterly) Range, Past 5 Years

View Net Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Total Long Term Debt (Quarterly) Benchmarks

View Net Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Skye Bioscience, Inc. Upgrade
Kyntra Bio, Inc. Upgrade
Myomo, Inc. Upgrade